These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38693042)

  • 1. The potential of the nutraceutical berberine in the treatment of hepatocellular carcinoma and other liver diseases such as NAFLD and NASH.
    Cervello M; Augello G; Cocco L; Ratti S; Follo MY; Martelli AM; Cusimano A; Montalto G; McCubrey JA
    Adv Biol Regul; 2024 May; 92():101032. PubMed ID: 38693042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Berberine prevents NAFLD and HCC by modulating metabolic disorders.
    Lin X; Zhang J; Chu Y; Nie Q; Zhang J
    Pharmacol Ther; 2024 Feb; 254():108593. PubMed ID: 38301771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma in the context of non-alcoholic steatohepatitis (NASH): recent advances in the pathogenic mechanisms.
    Lequoy M; Gigante E; Couty JP; Desbois-Mouthon C
    Horm Mol Biol Clin Investig; 2020 Feb; 41(1):. PubMed ID: 32112699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berberine Prevents Disease Progression of Nonalcoholic Steatohepatitis through Modulating Multiple Pathways.
    Wang Y; Tai YL; Zhao D; Zhang Y; Yan J; Kakiyama G; Wang X; Gurley EC; Liu J; Liu J; Liu J; Lai G; Hylemon PB; Pandak WM; Chen W; Zhou H
    Cells; 2021 Jan; 10(2):. PubMed ID: 33494295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease-Clinical and Pre-Clinical Overview and Systematic Review of the Literature.
    Ionita-Radu F; Patoni C; Nancoff AS; Marin FS; Gaman L; Bucurica A; Socol C; Jinga M; Dutu M; Bucurica S
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Potential Mechanisms of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease.
    Zhu X; Bian H; Gao X
    Molecules; 2016 Oct; 21(10):. PubMed ID: 27754444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin modulates innate immune-mediated inflammation and early progression of NAFLD-associated hepatocellular carcinoma in zebrafish.
    de Oliveira S; Houseright RA; Graves AL; Golenberg N; Korte BG; Miskolci V; Huttenlocher A
    J Hepatol; 2019 Apr; 70(4):710-721. PubMed ID: 30572006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play.
    Charrez B; Qiao L; Hebbard L
    World J Gastroenterol; 2016 Feb; 22(8):2494-502. PubMed ID: 26937137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Berberine attenuates non-alcoholic steatohepatitis by regulating chemerin/CMKLR1 signalling pathway and Treg/Th17 ratio.
    Lu Z; Lu F; Wu L; He B; Chen Z; Yan M
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Feb; 394(2):383-390. PubMed ID: 32524150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the Role of PPARβ/δ in NAFLD.
    Chen J; Montagner A; Tan NS; Wahli W
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29954129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study.
    Nakamura N; Hatano E; Iguchi K; Sato M; Kawaguchi H; Ohtsu I; Sakurai T; Aizawa N; Iijima H; Nishiguchi S; Tomono T; Okuda Y; Wada S; Seo S; Taura K; Uemoto S; Ikegawa M
    BMC Cancer; 2019 Jun; 19(1):621. PubMed ID: 31238892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Berberine in Non-Alcoholic Fatty Liver Disease-A Review.
    Koperska A; Wesołek A; Moszak M; Szulińska M
    Nutrients; 2022 Aug; 14(17):. PubMed ID: 36079717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease and hepatocellular carcinoma.
    Zoller H; Tilg H
    Metabolism; 2016 Aug; 65(8):1151-60. PubMed ID: 26907206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of FXR modulates SOCS3/Jak2/STAT3 signaling axis in a NASH-dependent hepatocellular carcinoma animal model.
    Attia YM; Tawfiq RA; Gibriel AA; Ali AA; Kassem DH; Hammam OA; Elmazar MM
    Biochem Pharmacol; 2021 Apr; 186():114497. PubMed ID: 33675775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Scoping Review on Lipocalin-2 and Its Role in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma.
    Krizanac M; Mass Sanchez PB; Weiskirchen R; Asimakopoulos A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma.
    Weinmann A; Alt Y; Koch S; Nelles C; Düber C; Lang H; Otto G; Zimmermann T; Marquardt JU; Galle PR; Wörns MA; Schattenberg JM
    BMC Cancer; 2015 Apr; 15():210. PubMed ID: 25884354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of RECK in Hepatobiliary Neoplasia Reveals Its Therapeutic Potential in NASH.
    Dashek RJ; Diaz C; Chandrasekar B; Rector RS
    Front Endocrinol (Lausanne); 2021; 12():770740. PubMed ID: 34745017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development.
    Jiang CM; Pu CW; Hou YH; Chen Z; Alanazy M; Hebbard L
    World J Gastroenterol; 2014 Nov; 20(44):16464-73. PubMed ID: 25469014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.
    Kanda T; Goto T; Hirotsu Y; Masuzaki R; Moriyama M; Omata M
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berberine directly targets AKR1B10 protein to modulate lipid and glucose metabolism disorders in NAFLD.
    Yang S; Cao SJ; Li CY; Zhang Q; Zhang BL; Qiu F; Kang N
    J Ethnopharmacol; 2024 Oct; 332():118354. PubMed ID: 38762210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.